Page last updated: 2024-11-12

cucurbit(8)uril

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cucurbit(8)uril: a macrocyclic polymer compound comprising 8 GLYCOLURIL units with methylene bridges [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID16133299
CHEBI ID51433
SCHEMBL ID16272341
MeSH IDM0494146

Synonyms (19)

Synonym
CHEBI:51433
cb[8]
cucurbit[8]uril
AKOS015915607
bdbm36284
sampl3, h3
bdbm36303
bdbm36310
SCHEMBL16272341
c8l ,
CONWISUOKHSUDR-UHFFFAOYSA-N
259886-51-6
Q27122603
BS-14119
D83708
cucurbit(8)uril
HY-103689
A856579
CS-0031079

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"Amyloid β is one of the peptides involved in the onset of Alzheimer's disease, yet the structure of the toxic species and its underlying mechanism remain elusive on account of the dynamic nature of the Aβ oligomerisation process."( Decreasing amyloid toxicity through an increased rate of aggregation.
Scherman, OA; Sonzini, S; Stanyon, HF, 2017
)
0.46

Pharmacokinetics

ExcerptReferenceRelevance
"The relatively non-toxic family of cucurbit[n]uril, Q[n], have shown considerable potential in vitro as drug delivery agents, with only a few examples of pharmacokinetic (PK) studies for drug⊂Q[n]."( Probing the pharmacokinetics of cucurbit[7, 8 and 10]uril: and a dinuclear ruthenium antimicrobial complex encapsulated in cucurbit[10]uril.
Collins, JG; Day, AI; Feterl, M; Gorle, AK; Keene, FR; Kinobe, R; Li, F; Ranson, M; Vine, KL; Warner, JM, 2017
)
0.46

Dosage Studied

ExcerptRelevanceReference
" The bioadaptability of the compounds was further examined through in vivo studies on mice, where intravenous administration of CB[7] showed a maximum tolerated dosage of 250 mg kg(-1), while oral administration of a CB[7]/CB[8] mixture showed a tolerance of up to 600 mg kg(-1)."( Toxicity of cucurbit[7]uril and cucurbit[8]uril: an exploratory in vitro and in vivo study.
Brix, K; Cullinane, C; Day, AI; Nau, WM; Uzunova, VD, 2010
)
0.36
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (166)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's13 (7.83)29.6817
2010's117 (70.48)24.3611
2020's36 (21.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.99

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.99 (24.57)
Research Supply Index5.12 (2.92)
Research Growth Index5.32 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (25.99)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (1.20%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other164 (98.80%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]